S. Frustaci

3.2k total citations · 1 hit paper
81 papers, 2.4k citations indexed

About

S. Frustaci is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, S. Frustaci has authored 81 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in S. Frustaci's work include Sarcoma Diagnosis and Treatment (28 papers), Vascular Tumors and Angiosarcomas (18 papers) and Cancer Treatment and Pharmacology (16 papers). S. Frustaci is often cited by papers focused on Sarcoma Diagnosis and Treatment (28 papers), Vascular Tumors and Angiosarcomas (18 papers) and Cancer Treatment and Pharmacology (16 papers). S. Frustaci collaborates with scholars based in Italy, Ukraine and Spain. S. Frustaci's co-authors include Angela Buonadonna, Antonino De Paoli, F. Gherlinzoni, Alessandro Comandone, Piero Picci, Diego Serraino, Elena Barbieri, Gaetano Apice, Alberto Azzarelli and Hassan Zmerly and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

S. Frustaci

81 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial

2001 506 citations S. Frustaci, F. Gherlinzoni et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Frustaci Italy	22	1.6k	1.4k	531	432	381	81	2.4k
A. Thyss France	26	1.6k 1.0×	1.1k 0.8×	238 0.4×	309 0.7×	458 1.2×	110	3.1k
Yang Yao China	29	1.2k 0.7×	1.1k 0.8×	333 0.6×	301 0.7×	694 1.8×	125	2.4k
L. Chaigneau France	21	998 0.6×	927 0.7×	251 0.5×	241 0.6×	186 0.5×	100	1.8k
Mukund S. Didolkar United States	20	951 0.6×	660 0.5×	587 1.1×	151 0.3×	319 0.8×	59	1.9k
Wei‐Xiang Qi China	24	1.1k 0.7×	940 0.7×	391 0.7×	310 0.7×	426 1.1×	109	2.1k
Tohru Nakagoe Japan	27	1.2k 0.8×	1.0k 0.7×	1.5k 2.8×	180 0.4×	428 1.1×	117	2.5k
Hideyuki Ishida Japan	26	1.5k 0.9×	970 0.7×	1.2k 2.2×	107 0.2×	329 0.9×	325	2.9k
Kazuhiro Sakamoto Japan	26	1.4k 0.9×	1.1k 0.8×	1.2k 2.2×	94 0.2×	466 1.2×	325	3.0k
Ryan S. Turley United States	24	652 0.4×	601 0.4×	719 1.4×	125 0.3×	355 0.9×	61	1.8k
Dusan Kotasek Australia	28	1.2k 0.7×	542 0.4×	183 0.3×	113 0.3×	448 1.2×	104	2.3k

Countries citing papers authored by S. Frustaci

Since Specialization

Citations

This map shows the geographic impact of S. Frustaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Frustaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Frustaci more than expected).

Fields of papers citing papers by S. Frustaci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Frustaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Frustaci. The network helps show where S. Frustaci may publish in the future.

Co-authorship network of co-authors of S. Frustaci

This figure shows the co-authorship network connecting the top 25 collaborators of S. Frustaci. A scholar is included among the top collaborators of S. Frustaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Frustaci. S. Frustaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gronchi, Alessandro, S. Frustaci, Mario Mercuri, et al.. (2012). Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group. Journal of Clinical Oncology. 30(8). 850–856. 120 indexed citations

Gronchi, Alessandro, Paolo Verderio, Antonino De Paoli, et al.. (2012). Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. Annals of Oncology. 24(3). 817–823. 61 indexed citations

Rossetto, Anna, et al.. (2012). Mesenchymal chondrosarcoma of the spleen: report of a case.. PubMed. 97(4). e10–5. 4 indexed citations

Pas, Tommaso De, Gerardo Rosati, Gianluca Spitaleri, et al.. (2011). Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination. Chemotherapy. 57(3). 217–224. 3 indexed citations

Celio, Luigi, S. Frustaci, Angela Buonadonna, et al.. (2010). Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. Supportive Care in Cancer. 19(8). 1217–1225. 76 indexed citations

Cecchin, Erika, Giuseppe Corona, Paola Biason, et al.. (2005). Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients. Clinical Cancer Research. 11(19). 6901–6907. 28 indexed citations

Bajetta, Emilio, Maria Di Bartolomeo, Luigi Mariani, et al.. (2004). Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinoma. Cancer. 100(2). 279–287. 115 indexed citations

Frustaci, S., et al.. (2003). Treatment of advanced disease and new drugs.. PubMed. 2(5). S48–50. 3 indexed citations

Comandone, Alessandro, et al.. (1998). Pharmacokinetics of Ifosfamide Administered According to Three Different Schedules in Metastatic Soft Tissue and Bone Sarcomas. Journal of Chemotherapy. 10(5). 385–393. 13 indexed citations

10.

Frustaci, S., Angela Buonadonna, Enzo Galligioni, et al.. (1997). Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study.. Journal of Clinical Oncology. 15(4). 1418–1426. 42 indexed citations

11.

Toffoli, Giuseppe, S. Frustaci, Renato Talamini, et al.. (1992). Expression of MDR1 and GST-π in human soft tissue sarcomas: Relation to drug resistance and biological aggressiveness. Annals of Oncology. 3(1). 63–69. 43 indexed citations

12.

Frustaci, S., Andrea Freschi, Re G, et al.. (1992). Feasibility and efficacy of arginine 2-mercaptoethanesulfonate (ARGIMESNA) in the prevention of hemorragic cystitis from ifosfamide (IFO). Annals of Oncology. 3. S115–S118. 2 indexed citations

13.

Serraino, Diego, Silvia Franceschi, Renato Talamini, S. Frustaci, & Carlo La Vecchia. (1991). Non-occupational risk factors for adult soft-tissue sarcoma in northern Italy. Cancer Causes & Control. 2(3). 157–164. 21 indexed citations

14.

Figoli, F., Enzo Galligioni, Diana Crivellari, et al.. (1991). Evaluation of Two Consecutive Regimens in Advanced Gastric Cancer. Cancer Investigation. 9(3). 257–262. 6 indexed citations

15.

Crivellari, Diana, Enzo Galligioni, S. Frustaci, et al.. (1990). Cisplatin and Mitomycin C in Advanced Chemotherapy-Refractory Breast Cancer. Tumori Journal. 76(3). 234–237. 4 indexed citations

16.

Barzan, Luigi, Giovanni Franchin, S. Frustaci, Antonino De Paoli, & R Comoretto. (1990). Carcinoma of the nasal vestibule: Report of 12 cases. The Journal of Laryngology & Otology. 104(1). 9–11. 10 indexed citations

17.

Crivellari, Diana, Enzo Galligioni, S. Frustaci, et al.. (1989). Low-Dose Aminoglutethimide Plus Steroid Replacement in Advanced Breast Cancer Patients Resistant to Conventional Therapies. Cancer Investigation. 7(2). 113–116. 1 indexed citations

18.

Galligioni, Enzo, Luciano Canobbio, F. Figoli, et al.. (1987). Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: A phase II study. European Journal of Cancer and Clinical Oncology. 23(6). 657–661. 7 indexed citations

19.

Frustaci, S., Luigi Barzan, Salvatore Tumolo, et al.. (1986). Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients. Cancer. 57(6). 1118–1123. 20 indexed citations

20.

Frustaci, S., Umberto Tirelli, & Salvatore Tumolo. (1983). High dose metoclopramide in cisplatin treated patients. 2(2). 75–77. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact